Astral Ltd shares suffered a sharp sell-off on Monday, falling nearly 10% after the company's board approved a plan to demerge its chemicals business into a separate listed entity.
The stock slid as much as 9.91% to ₹1,339 on the Bombay Stock Exchange, marking one of the steepest single-day declines for the industrial conglomerate in recent months.
The move signals a clear lack of investor confidence in the restructuring strategy, despite the company's stated aim to sharpen business focus.
The market's negative reaction underscores a growing skepticism toward corporate spin-offs in the current environment, where investors are prioritizing consolidated growth and margin stability over structural complexity.
While demergers are often viewed as a way to unlock value by allowing each business unit to trade on its own merits, Astral's case highlights the risks of execution uncertainty and potential valuation discounts for the newly formed entities.
The chemicals segment, which includes adhesives and paints, faces intense competition and margin pressure, factors that may have weighed heavily on investor sentiment.